Recap: Tango Therapeutics Q4 Earnings

Tango Therapeutics TNGX reported its Q4 earnings results on Monday, March 18, 2024 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Tango Therapeutics missed estimated earnings by -14.000000000000002%, reporting an EPS of $-0.32 versus an estimate of $-0.28.

Revenue was down $980 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 6.0% drop in the share price the next day.

Here's a look at Tango Therapeutics's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.34 -0.34 -0.35 -0.35
EPS Actual -0.23 -0.23 -0.32 -0.33
Revenue Estimate 7.32M 6.95M 6.71M 6.44M
Revenue Actual 10.73M 14.60M 5.77M 6.41M

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Tango Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!